Hilary Taubman-Dye
Overview
Taubman-Dye purchased an interest in Celadon Technology Fund VII, which held TheranosTheranosTheranos was a blood-testing company founded in 2003 by Elizabeth Holmes and based in Palo Alto, California, which offered retail testing with Walgreens and was valued at up to $9 billion before regulatory sanctions and criminal charges over alleged fraud in its technology and financial claims led to its dissolution in 2018.Open the full entry shares.[1]
Contents4 sections
Key facts
2015Investment and Closing Dispute
Taubman-Dye said she invested just over $100,000 in Celadon. On December 15, 2015, the fund purchased 410,000 Theranos shares from another investor.[1]
2016–2018Investor Litigation
Taubman-Dye sued with Robert ColmanRobert ColmanRobert Colman co-founded Robertson Stephens and invested indirectly in Theranos.Open the full entry, seeking to represent indirect investors. On May 31, 2018, the court denied class certification because of individualized reliance issues and other deficiencies, without thereby rejecting every underlying substantive claim.[1]